P3 Health Partners Inc. (NASDAQ:PIII – Get Free Report) was the recipient of a significant drop in short interest during the month of November. As of November 30th, there was short interest totalling 818,000 shares, a drop of 19.8% from the November 15th total of 1,020,000 shares. Approximately 0.9% of the company’s stock are short sold. Based on an average daily trading volume, of 739,600 shares, the days-to-cover ratio is currently 1.1 days.
Institutional Trading of P3 Health Partners
Institutional investors and hedge funds have recently made changes to their positions in the company. Renaissance Technologies LLC increased its position in shares of P3 Health Partners by 188.1% during the second quarter. Renaissance Technologies LLC now owns 111,800 shares of the company’s stock valued at $50,000 after acquiring an additional 73,000 shares during the last quarter. Geode Capital Management LLC boosted its position in P3 Health Partners by 115.2% in the third quarter. Geode Capital Management LLC now owns 1,029,259 shares of the company’s stock worth $398,000 after purchasing an additional 550,925 shares during the last quarter. Emfo LLC grew its stake in P3 Health Partners by 39.8% in the 2nd quarter. Emfo LLC now owns 1,427,689 shares of the company’s stock valued at $643,000 after purchasing an additional 406,418 shares during the period. Finally, Armistice Capital LLC purchased a new stake in shares of P3 Health Partners during the 2nd quarter valued at $3,557,000. Hedge funds and other institutional investors own 7.75% of the company’s stock.
Wall Street Analysts Forecast Growth
Separately, TD Cowen cut their price target on P3 Health Partners from $0.90 to $0.25 and set a “hold” rating for the company in a research note on Wednesday, November 20th.
P3 Health Partners Stock Down 3.9 %
NASDAQ:PIII traded down $0.01 during trading hours on Monday, hitting $0.20. 371,865 shares of the company traded hands, compared to its average volume of 469,347. The company has a quick ratio of 0.53, a current ratio of 0.53 and a debt-to-equity ratio of 1.11. The company has a market cap of $70.72 million, a PE ratio of -0.24 and a beta of 0.98. The firm’s 50-day simple moving average is $0.31 and its 200-day simple moving average is $0.45. P3 Health Partners has a one year low of $0.19 and a one year high of $1.78.
P3 Health Partners Company Profile
P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.
Further Reading
- Five stocks we like better than P3 Health Partners
- Investing in Commodities: What Are They? How to Invest in Them
- Semtech Stock Climbs as AI Boom Drives Turnaround Success
- How Can Investors Benefit From After-Hours Trading
- 3 Companies Leading the Way With Aggressive Stock Buybacks
- Most Volatile Stocks, What Investors Need to Know
- Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?
Receive News & Ratings for P3 Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for P3 Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.